Circulating levels of Th1, Th17, and Th22 cells are increased in psoriasis patients compared to healthy volunteers, and the frequency of Th1 and Th17 cells is decreased after anti-TNF-α therapy [158]. The gene discussed is TNF; the disease is psoriasis.